About Galen Partners

Since our founding in 1990, we have been exclusively focused on identifying and building leading healthcare companies. Over that time, we have created an investment portfolio with an aggregate market value of over $10 billion and helped over 80 of our portfolio companies navigate through the complicated paths of mergers and acquisitions, public offerings, and debt financings. Galen has earned recognition as one of the most influential firms in healthcare growth equity investing.

We welcome the opportunity to meet with those who share our belief in the opportunities available in today’s healthcare marketplace, and with those who recognize the potential rewards resulting from a disciplined, collaborative approach to building sustainable businesses.

Where Did We Get the Name “Galen”?

Our firm takes its name from Galen of Pergamon, a Greek physician, writer, medical researcher, surgeon, and philosopher who lived in the second and third century.  He is considered to be one of the most influential and accomplished of all physicians in antiquity and was instrumental in the development of the fields of anatomy, physiology, pathology, pharmacology, neurology, and logic.

Galen was the first to identify that there are distinct differences between venous and arterial blood.  He performed a technique for cataract surgery that remains similar to modern approaches.  And his work in anatomy remained unsurpassed until the 16th century.  He was noted for being perpetually inquisitive and his approach stressed independent judgement and empiricism.

Galen of Pergamon fundamentally believed in an interdisciplinary approach.  He regarded medicine as a field that was best practiced by utilizing theory, observation, and experimentation in conjunction.

We at Galen Partners are proud to take many of these same principles – deep healthcare expertise, an inquisitive and empirical approach, independent judgement, and an excellent reputation built over several decades – as we aim to build today’s leading healthcare companies.